By Nate Raymond NEW YORK (Reuters) - Bank of America Corp

New Post Public Reply Private Reply Replies (1) Message Board
Rhythm Guitar
By Nate Raymond
NEW YORK (Reuters) - Bank of America Corp (NYS:BAC) was found liable for fraud on Wednesday over defective mortgages sold by its Countrywide unit, a major win for the U.S. government in one of the few trials stemming from the financial crisis.
After a four-week trial, a federal jury in New York found the bank liable on one civil fraud charge. Countrywide originated shoddy home loans in a process called "Hustle" and sold them to government mortgage giants Fannie Mae (OBB:FNMA) and Freddie Mac (OBB:FMCC), the government said.
The four men and six women on the jury also found former Countrywide executive Rebecca Mairone liable on the one fraud charge she faced.
The U.S. Justice Department has said it would seek up to $848.2 million (524.5 million pounds), the gross loss it said Fannie and Freddie suffered on the loans. But it will be up to U.S. District Judge Jed Rakoff to decide on the penalty. Arguments on how the judge will assess penalties are set for December 5.
Any penalty would add to the more than $40 billion Bank of America has spent on disputes stemming from the 2008 financial crisis.
"The jury's decision concerned a single Countrywide program that lasted several months and ended before Bank of America's acquisition of the company," Bank of America spokesman Lawrence Grayson said. "We will evaluate our options for appeal."
Marc Mukasey, a lawyer for Mairone, called his client a "woman of integrity, ethics and honesty," adding they would fight on. "She never engaged in fraud, because there was no fraud," he said.
Wednesday's verdict was a major victory for the Justice Department, which has been criticized for failing to hold banks and executives accountable for their roles in the events leading up to the financial crisis.
The government continues to investigate banks for conduct related to the financial crisis. The verdict comes as the government is negotiating a $13 billion settlement with JPMorgan Chase & Co (NYS:JPM) to resolve a number of probes and claims arising from its mortgage business, including the sale of mortgage bonds.
RISKY LOANS
The lawsuit stemmed from a whistleblower case originally brought by Edward O'Donnell, a former Countrywide executive who stands to earn up to $1.6 million for his role.
The case centred on a program called the "High Speed Swim Lane" - also called "HSSL" or "Hustle" - that government lawyers said Countrywide started in 2007.
The Justice Department contended that fraud and other defects were rampant in HSSL loans because Countrywide eliminated loan-quality checkpoints and paid employees based on loan volume and speed.
The Justice Department said the process was overseen by Mairone, a former chief operating officer of Countrywide's Full Spectrum Lending division. Mairone is now a managing director at JPMorgan.
Amy Bonitatibus, a JPMorgan spokeswoman, said, "We are reviewing the decision."
About 43 percent of the loans sold to the mortgage giants were materially defective, the government said.
Bank of America bought Countrywide in July 2008. Two months later, the government took over Fannie and Freddie.
Bank of America and Mairone denied wrongdoing. Lawyers for the bank sought to show the jury that Countrywide had tried to ensure it was issuing quality loans and that no fraud occurred.
The lawsuit was the first financial crisis-related case against a bank by the Justice Department to go to trial under the Financial Institutions Reform, Recovery, and Enforcement Act
(FIRREA).
The law, passed in the wake of the 1980s savings-and-loan scandals, covers fraud affecting federally insured financial institutions.
The Justice Department, and particularly lawyers in the office of U.S. Attorney Preet Bharara in the Southern District of New York, have sought to dust off the rarely used law and bring cases against banks accused of fraud.
Among its attractions, FIRREA provides a statute of limitations of 10 years and allows the government to bring civil cases for alleged criminal wrongdoing.
Virginia Gibson, a lawyer at the law firm Hogan Lovells, said the Bank of America verdict was a "big deal because it shows the scope of a tool the government has not used frequently since its inception."
Gibson and other lawyers say any appeal by Bank of America would likely focus on a ruling made by the judge before the trial that endorsed a government position that it can bring a FIRREA case against a bank when the bank itself was the financial institution affected by the fraud.
The case was one of three lawsuits in New York where judges had endorsed that interpretation. Banks have generally argued that the interpretation is contrary to the intent of Congress, which they said is more focused on others committing fraud on banks.
Bank of America's case was the first to go to trial, a rarity given that banks more typically choose to settle government claims instead of face a jury. But Bank of America had said that it "can't be expected to compensate every entity that claims losses that actually were caused by the economic downturn."
In a statement, Bharara said Bank of America "chose to defend Countrywide's conduct with all its might and money, claiming there was no case here."
"This office will never hesitate to go to trial to expose fraudulent corporate conduct and to hold companies accountable, particularly when it has caused such harm to the public," Bharara said.
In late afternoon trading, Bank of America shares were down 27 cents at $14.25 on the New York Stock Exchange.
The case is U.S. ex rel. O'Donnell v. Bank of America Corp et al, U.S. District Court, Southern District of New York, No. 12-01422.
(Reporting by Nate Raymond; Additional reporting by Jonathan Stempel; Editing by Leslie Gevirtz and Edwina Gibbs)

Fannie Mae (FNMA) Stock Research Links

FNMA Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Arch Biopartners Secures Funding Through Private Placement

Updated Category News Views 147

Arch Biopartners Announces Private Placement to Enhance Growth Arch Biopartners Inc. is excited to share that it has successfully arranged a non-brokered private placement. This offering consists of 225,806 common shares priced at $1.55 each, aiming to raise gross proceeds of $350,000 CAD. This strategic move positions Arch to bolster its working capital, which is...

Continue Reading
Revolutionizing Laboratory Automation: Trilobio's New Platform

Updated Category News Views 376

Trilobio Unveils Comprehensive Lab Automation Platform At the forefront of advancing biology research, Trilobio has introduced a groundbreaking whole lab automation platform at a major conference. This innovative platform integrates robotics, lab equipment, and software, creating a streamlined solution for researchers facing workflow challenges. Transforming Genetic...

Continue Reading
Shell Expands Share Buyback Program with Recent Purchases

Updated Category News Views 61

Shell's Strategic Share Buyback Initiative Shell plc recently announced a significant purchase of shares for cancellation, reaffirming its dedication to enhancing shareholder value. On a specific date, the company acquired a substantial number of shares, a move that is part of the broader share buyback program that was outlined in detail previously. Details of Share...

Continue Reading
Constellium SE to Host Earnings Call for Q3 2024 Results

Updated Category News Views 44

Constellium SE to Share Q3 2024 Financial Update Constellium SE (NYSE: CSTM) is preparing to reveal its third-quarter 2024 results during a special conference call and webcast. This event will occur on a Wednesday morning, aiming to keep stakeholders informed and engaged with the company's latest developments. Details of the Upcoming Conference Call The conference call is...

Continue Reading
Streamline Health Strengthens Partnership with New Contract

Updated Category News Views 133

Expanding Horizons: Streamline Health’s New Contract Streamline Health Solutions, Inc. (NASDAQ: STRM) has recently announced a notable contract for its RevID technology with a health system based in Kentucky. This particular system is a 120-bed facility that utilizes Oracle Health's EHR, marking a significant step in Streamline Health's expansion within the healthcare...

Continue Reading